Cargando…
P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430487/ http://dx.doi.org/10.1097/01.HS9.0000972544.91452.b7 |
| _version_ | 1785090975425626112 |
|---|---|
| author | Yokoyama, Shota Ara, Takahide Harada, Shinpei Mori, Yuto Hasegawa, Yuta Ohigashi, Hiroyuki Matsukawa, Toshihiro Yasumoto, Atsushi Shiratori, Souichi Onozawa, Masahiro Nakagawa, Masao Kahata, Kaoru Endo, Tomoyuki Hashimoto, Daigo Goto, Hideki Teshima, Takanori |
| author_facet | Yokoyama, Shota Ara, Takahide Harada, Shinpei Mori, Yuto Hasegawa, Yuta Ohigashi, Hiroyuki Matsukawa, Toshihiro Yasumoto, Atsushi Shiratori, Souichi Onozawa, Masahiro Nakagawa, Masao Kahata, Kaoru Endo, Tomoyuki Hashimoto, Daigo Goto, Hideki Teshima, Takanori |
| author_sort | Yokoyama, Shota |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430487 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104304872023-08-17 P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY Yokoyama, Shota Ara, Takahide Harada, Shinpei Mori, Yuto Hasegawa, Yuta Ohigashi, Hiroyuki Matsukawa, Toshihiro Yasumoto, Atsushi Shiratori, Souichi Onozawa, Masahiro Nakagawa, Masao Kahata, Kaoru Endo, Tomoyuki Hashimoto, Daigo Goto, Hideki Teshima, Takanori Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430487/ http://dx.doi.org/10.1097/01.HS9.0000972544.91452.b7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Yokoyama, Shota Ara, Takahide Harada, Shinpei Mori, Yuto Hasegawa, Yuta Ohigashi, Hiroyuki Matsukawa, Toshihiro Yasumoto, Atsushi Shiratori, Souichi Onozawa, Masahiro Nakagawa, Masao Kahata, Kaoru Endo, Tomoyuki Hashimoto, Daigo Goto, Hideki Teshima, Takanori P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY |
| title | P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY |
| title_full | P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY |
| title_fullStr | P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY |
| title_full_unstemmed | P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY |
| title_short | P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY |
| title_sort | p1414: crp is a convenient predictive marker of the antipyretic effect of tocilizumab on crs during car-t cell therapy |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430487/ http://dx.doi.org/10.1097/01.HS9.0000972544.91452.b7 |
| work_keys_str_mv | AT yokoyamashota p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT aratakahide p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT haradashinpei p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT moriyuto p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT hasegawayuta p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT ohigashihiroyuki p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT matsukawatoshihiro p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT yasumotoatsushi p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT shiratorisouichi p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT onozawamasahiro p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT nakagawamasao p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT kahatakaoru p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT endotomoyuki p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT hashimotodaigo p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT gotohideki p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy AT teshimatakanori p1414crpisaconvenientpredictivemarkeroftheantipyreticeffectoftocilizumaboncrsduringcartcelltherapy |